CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

Medicus Pharma offers high-risk, high-reward potential, with its novel SkinJect patch for basal cell carcinoma and Antev ...

There are people trapped under rubble, wounded without medicine, and displaced without shelter,' spokesman says ...

Dr. Lily Ackermann discussed inpatient diabetes care, focusing on real-world decisions and personalized treatment using ...

IcoSema, a combination therapy of basal insulin icodec and semaglutide, achieves a noninferior reduction in A1c levels compared with basal-bolus therapy in adults with T2D.

Dystonia involves involuntary muscle contractions, but you're not out of options. Discover how botulinum toxin, DBS, and ...

There seems to be a lower volume in important parts of the brain related to behavior, emotional regulation, and impulse ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase 3 clinical trials ...

The esophagus, which is not normally exposed to acid, adapts to acid reflux by becoming more like the stomach or the ...

Today, findings from the QWINT-1 study found once-weekly insulin efsitora alfa (efsitora) lowered blood glucose (blood sugar) levels as effectively as daily basal insulin in insulin-naïve type 2 ...

Breakthrough computer models reveal how the bladder lining regenerates. They show how its cells divide and mature, similar to ...